The emerging role of SPOP protein in tumorigenesis and cancer therapy

Yizuo Song1, Yichi Xu1, Chunyu Pan1

  • 1Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Wenzhou Medical University, No. 109 Xueyuan Xi Road, Wenzhou, 325027, Zhejiang, China.

Molecular Cancer
|January 6, 2020
PubMed

Insights

Speckle-type POZ protein (SPOP) has a dual role in cancer, suppressing tumors in some cancers but promoting them in others, like kidney cancer. Its function varies by cancer type, making it a potential therapeutic target.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Speckle-type POZ protein (SPOP) is a key component of the cullin-RING E3 ligase complex.
  • SPOP plays a context-dependent role in tumorigenesis, acting as a tumor suppressor in many cancers but an oncogene in kidney cancer.

Purpose of the Study:

  • To review the structure, regulation, and function of SPOP in human cancer.
  • To highlight SPOP's critical role in tumorigenesis across different cancer types.
  • To evaluate SPOP as a potential therapeutic target for cancer treatment.

Main Methods:

  • Literature review of studies on SPOP in human cancer.
  • Analysis of physiological (animal models), pathological (human specimens), and biochemical (ubiquitin substrates) evidence.
  • Examination of SPOP's cancer type-specific functions.

Main Results:

  • SPOP suppresses tumorigenesis in prostate, lung, colon, gastric, and liver cancers.
  • SPOP exhibits oncogenic functions in kidney cancer.
  • The role of SPOP in thyroid, cervical, ovarian, bone, and neurologic cancers requires further investigation.

Conclusions:

  • SPOP's biological functions are cancer type-specific.
  • SPOP's dual role in cancer progression warrants further research.
  • SPOP represents a promising therapeutic target for various human malignancies.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.8K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.3K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.8K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
5.2K